News and Press Releases
The joining of Northway Biotech to a Lithuanian science and business consortium collaborating with the Massachusetts Institute of Technology (MIT, USA) marks a new stage in international life sciences cooperation.…
January 29, 2026
Hørsholm, Denmark, 28 January 2026 – ExpreS2ion Biotech Holding AB's affiliate ExpreS2ion Biotechnologies ApS ("ExpreS2ion"), a clinical-stage biotechnology company with a focused pipeline of vaccine candidates targeting infectious diseases and…
January 28, 2026
Vilnius, Lithuania, October 14, 2025 – Northway Biotech ("NBT"), a Contract Development and Manufacturing Organization (CDMO), is delighted to announce its recognition as a winner of the Outsourced Pharma and…
October 25, 2025
At this year's Life Sciences Baltics 2025 in Vilnius, Korean Pharm-Edaily (팜이데일리), a leading South Korean life sciences publication, highlighted Lithuania's rapidly growing biotech ecosystem, with Northway Biotech recognized for…
October 1, 2025
Boston, MA and Vilnius, Lithuania, July 29, 2025 - Diorasis Therapeutics ("DTx"), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic partnership with Northway…
July 29, 2025
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin • Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal…
July 15, 2025